1. Home
  2. OBK vs CRGX Comparison

OBK vs CRGX Comparison

Compare OBK & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBK
  • CRGX
  • Stock Information
  • Founded
  • OBK 1912
  • CRGX 2021
  • Country
  • OBK United States
  • CRGX United States
  • Employees
  • OBK N/A
  • CRGX N/A
  • Industry
  • OBK Major Banks
  • CRGX
  • Sector
  • OBK Finance
  • CRGX
  • Exchange
  • OBK Nasdaq
  • CRGX Nasdaq
  • Market Cap
  • OBK 978.3M
  • CRGX 964.5M
  • IPO Year
  • OBK 2018
  • CRGX 2023
  • Fundamental
  • Price
  • OBK $31.39
  • CRGX $20.37
  • Analyst Decision
  • OBK Buy
  • CRGX Strong Buy
  • Analyst Count
  • OBK 4
  • CRGX 7
  • Target Price
  • OBK $35.75
  • CRGX $30.33
  • AVG Volume (30 Days)
  • OBK 76.2K
  • CRGX 162.3K
  • Earning Date
  • OBK 10-23-2024
  • CRGX 11-21-2024
  • Dividend Yield
  • OBK 1.91%
  • CRGX N/A
  • EPS Growth
  • OBK N/A
  • CRGX N/A
  • EPS
  • OBK 2.43
  • CRGX N/A
  • Revenue
  • OBK $343,330,000.00
  • CRGX N/A
  • Revenue This Year
  • OBK N/A
  • CRGX N/A
  • Revenue Next Year
  • OBK $4.22
  • CRGX N/A
  • P/E Ratio
  • OBK $12.91
  • CRGX N/A
  • Revenue Growth
  • OBK N/A
  • CRGX N/A
  • 52 Week Low
  • OBK $27.69
  • CRGX $13.14
  • 52 Week High
  • OBK $37.56
  • CRGX $33.92
  • Technical
  • Relative Strength Index (RSI)
  • OBK 46.47
  • CRGX 49.30
  • Support Level
  • OBK $31.29
  • CRGX $19.10
  • Resistance Level
  • OBK $32.50
  • CRGX $22.56
  • Average True Range (ATR)
  • OBK 0.94
  • CRGX 1.41
  • MACD
  • OBK -0.06
  • CRGX -0.13
  • Stochastic Oscillator
  • OBK 31.76
  • CRGX 30.38

About OBK Origin Bancorp Inc.

Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

Share on Social Networks: